Skip to content
PetMedix

PetMedix

Biotech·United Kingdom·Exited 2023·Held 3yr
Entry
2020
Hold
3yr
Exit
2023

Who owns PetMedix?

PetMedix was owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage) from 2020 to 2023, exited via Trade Sale. Across its history, PetMedix has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-11

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2023.
  • ·Average hold across 2 realized cycles: 4 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2019 · 2023
Parkwalk Advisors
2019 · 2023(4yr) · Parkwalk Opportunities EIS Fund · 2009 · VC
Trade Sale · to
MOIC
Cambridge Innovation Capital
2020 · 2023(3yr) · CIC Fund II · 2022 · VC
Trade Sale · to
MOIC
Track PetMedix

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PetMedix.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue